In the present study, it was determined that azomethine group compounds in AGS gastric cancer, contrary to the mentioned studies, significantly reduced TOP2A gene expression levels and were associated with a good prognosis for gastric cancer. The gene discussed is TOP2A; the disease is gastric cancer.